Literature DB >> 31017331

Molecular dynamics investigation of a redox switch in the anti-HIV protein SAMHD1.

Kajwal Kumar Patra1, Akash Bhattacharya2, Swati Bhattacharya1.   

Abstract

HIV-1 is restricted in macrophages and certain quiescent myeloid cells due to a "Scorched Earth" dNTP starvation strategy attributed to the sterile alpha motif and HD domain protein-SAMHD1. Active SAMHD1 tetramers are assembled by GTP-Mg+2-dNTP cross bridges and cleave the triphosphate groups of dNTPs at a K m of ~10 μM, which is consistent with dNTP concentrations in cycling cells, but far higher than the equivalent concentration in quiescent cells. Given the substantial disparity between the dNTP concentrations required to activate SAMHD1 tetramers (~10 μM) and the dNTP concentrations in noncycling cells (~10 nM), the possibility of alternate enzymatically active forms of SAMHD1, including monomers remains open. In particular, the possibility of redox regulation of such monomers is also an open question. There have been experimental studies on the regulation of SAMHD1 by Glutathione driven redox reactions recently. Therefore, in this work, we have performed all-atom molecular dynamics simulations to study the dynamics of monomeric SAMHD1 constructs in the context of the three redox-susceptible Cysteine residues and compared them to monomers assembled within a tetramer. Our results indicate that assembly into a tetramer causes ordering of the catalytic core and increased solvent accessibility of the Catalytic Site. We have also found that glutathionylation of surface exposed C522 causes long range allosteric disruptions extending into the protein core. Finally, we see evidence suggesting a transient interaction between C522 and C341. Such a disulfide linkage has been hypothesized by experimental models, but has never been observed in crystal structures before.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  HIV-1 restriction factor; SAMHD1; all atom MD simulations; redox regulation

Mesh:

Substances:

Year:  2019        PMID: 31017331     DOI: 10.1002/prot.25701

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  6 in total

1.  xCT/SLC7A11 antiporter function inhibits HIV-1 infection.

Authors:  Jesse Rabinowitz; Hamayun J Sharifi; Hunter Martin; Anthony Marchese; Michael Robek; Binshan Shi; Alexander A Mongin; Carlos M C de Noronha
Journal:  Virology       Date:  2021-01-20       Impact factor: 3.616

Review 2.  Mechanistic Interplay between HIV-1 Reverse Transcriptase Enzyme Kinetics and Host SAMHD1 Protein: Viral Myeloid-Cell Tropism and Genomic Mutagenesis.

Authors:  Nicole E Bowen; Adrian Oo; Baek Kim
Journal:  Viruses       Date:  2022-07-26       Impact factor: 5.818

3.  Resin-Assisted Capture Coupled with Isobaric Tandem Mass Tag Labeling for Multiplexed Quantification of Protein Thiol Oxidation.

Authors:  Matthew J Gaffrey; Nicholas J Day; Xiaolu Li; Wei-Jun Qian
Journal:  J Vis Exp       Date:  2021-06-21       Impact factor: 1.355

4.  Tetraspanin CD81 regulates HSV-1 infection.

Authors:  Beatriz Benayas; Isabel Sastre; Soraya López-Martín; Adrian Oo; Baek Kim; Maria J Bullido; Jesús Aldudo; María Yáñez-Mó
Journal:  Med Microbiol Immunol       Date:  2020-06-04       Impact factor: 4.148

Review 5.  SAMHD1 Functions and Human Diseases.

Authors:  Si'Ana A Coggins; Bijan Mahboubi; Raymond F Schinazi; Baek Kim
Journal:  Viruses       Date:  2020-03-31       Impact factor: 5.048

6.  Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy.

Authors:  Sean G Rudd; Nikolaos Tsesmetzis; Kumar Sanjiv; Cynthia Bj Paulin; Lakshmi Sandhow; Juliane Kutzner; Ida Hed Myrberg; Sarah S Bunten; Hanna Axelsson; Si Min Zhang; Azita Rasti; Petri Mäkelä; Si'Ana A Coggins; Sijia Tao; Sharda Suman; Rui M Branca; Georgios Mermelekas; Elisée Wiita; Sun Lee; Julian Walfridsson; Raymond F Schinazi; Baek Kim; Janne Lehtiö; Georgios Z Rassidakis; Katja Pokrovskaja Tamm; Ulrika Warpman-Berglund; Mats Heyman; Dan Grandér; Sören Lehmann; Thomas Lundbäck; Hong Qian; Jan-Inge Henter; Torsten Schaller; Thomas Helleday; Nikolas Herold
Journal:  EMBO Mol Med       Date:  2020-01-17       Impact factor: 12.137

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.